Table S2 from A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity Article Swipe
Michael L. Miller
,
Nathan Fishkin
,
Wěi Li
,
Kathleen R. Whiteman
,
Yelena Kovtun
,
Emily E. Reid
,
Katie E. Archer
,
Erin K. Maloney
,
Charlene A. Audette
,
Michele Mayo
,
Alan Wilhelm
,
Holly A. Modafferi
,
Rajeeva Singh
,
Jan Pinkas
,
Victor S. Goldmacher
,
John M. Lambert
,
Ravi Chari
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22508386.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22508386.v1
Comparative in vitro potency of IGNs with a diimine (1), monoimine (3), and diamine (2) towards hematologic and solid tumor cell lines
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1535-7163.22508386.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362623560
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362623560Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1535-7163.22508386.v1Digital Object Identifier
- Title
-
Table S2 from A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating ActivityWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-03Full publication date if available
- Authors
-
Michael L. Miller, Nathan Fishkin, Wěi Li, Kathleen R. Whiteman, Yelena Kovtun, Emily E. Reid, Katie E. Archer, Erin K. Maloney, Charlene A. Audette, Michele Mayo, Alan Wilhelm, Holly A. Modafferi, Rajeeva Singh, Jan Pinkas, Victor S. Goldmacher, John M. Lambert, Ravi ChariList of authors in order
- Landing page
-
https://doi.org/10.1158/1535-7163.22508386.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1535-7163.22508386.v1Direct OA link when available
- Concepts
-
Conjugate, Potency, Drug, In vitro, DNA, Chemistry, Antibody, Pharmacology, Cancer research, Molecular biology, Biology, Biochemistry, Immunology, Mathematics, Mathematical analysisTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362623560 |
|---|---|
| doi | https://doi.org/10.1158/1535-7163.22508386.v1 |
| ids.doi | https://doi.org/10.1158/1535-7163.22508386.v1 |
| ids.openalex | https://openalex.org/W4362623560 |
| fwci | 0.0 |
| type | preprint |
| title | Table S2 from A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10755 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9902999997138977 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | HER2/EGFR in Cancer Research |
| topics[1].id | https://openalex.org/T13160 |
| topics[1].field.id | https://openalex.org/fields/16 |
| topics[1].field.display_name | Chemistry |
| topics[1].score | 0.9804999828338623 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1605 |
| topics[1].subfield.display_name | Organic Chemistry |
| topics[1].display_name | Synthesis and Biological Evaluation |
| topics[2].id | https://openalex.org/T11395 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9794999957084656 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Radiopharmaceutical Chemistry and Applications |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C197336794 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6941384673118591 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q5161150 |
| concepts[0].display_name | Conjugate |
| concepts[1].id | https://openalex.org/C57992300 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6517889499664307 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2066956 |
| concepts[1].display_name | Potency |
| concepts[2].id | https://openalex.org/C2780035454 |
| concepts[2].level | 2 |
| concepts[2].score | 0.560910165309906 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[2].display_name | Drug |
| concepts[3].id | https://openalex.org/C202751555 |
| concepts[3].level | 2 |
| concepts[3].score | 0.521868109703064 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[3].display_name | In vitro |
| concepts[4].id | https://openalex.org/C552990157 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5048094987869263 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7430 |
| concepts[4].display_name | DNA |
| concepts[5].id | https://openalex.org/C185592680 |
| concepts[5].level | 0 |
| concepts[5].score | 0.4978213310241699 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[5].display_name | Chemistry |
| concepts[6].id | https://openalex.org/C159654299 |
| concepts[6].level | 2 |
| concepts[6].score | 0.49463793635368347 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[6].display_name | Antibody |
| concepts[7].id | https://openalex.org/C98274493 |
| concepts[7].level | 1 |
| concepts[7].score | 0.41680359840393066 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[7].display_name | Pharmacology |
| concepts[8].id | https://openalex.org/C502942594 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3626246154308319 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[8].display_name | Cancer research |
| concepts[9].id | https://openalex.org/C153911025 |
| concepts[9].level | 1 |
| concepts[9].score | 0.33821266889572144 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[9].display_name | Molecular biology |
| concepts[10].id | https://openalex.org/C86803240 |
| concepts[10].level | 0 |
| concepts[10].score | 0.2788214087486267 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[10].display_name | Biology |
| concepts[11].id | https://openalex.org/C55493867 |
| concepts[11].level | 1 |
| concepts[11].score | 0.2344309389591217 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[11].display_name | Biochemistry |
| concepts[12].id | https://openalex.org/C203014093 |
| concepts[12].level | 1 |
| concepts[12].score | 0.22591325640678406 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[12].display_name | Immunology |
| concepts[13].id | https://openalex.org/C33923547 |
| concepts[13].level | 0 |
| concepts[13].score | 0.09598684310913086 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[13].display_name | Mathematics |
| concepts[14].id | https://openalex.org/C134306372 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7754 |
| concepts[14].display_name | Mathematical analysis |
| keywords[0].id | https://openalex.org/keywords/conjugate |
| keywords[0].score | 0.6941384673118591 |
| keywords[0].display_name | Conjugate |
| keywords[1].id | https://openalex.org/keywords/potency |
| keywords[1].score | 0.6517889499664307 |
| keywords[1].display_name | Potency |
| keywords[2].id | https://openalex.org/keywords/drug |
| keywords[2].score | 0.560910165309906 |
| keywords[2].display_name | Drug |
| keywords[3].id | https://openalex.org/keywords/in-vitro |
| keywords[3].score | 0.521868109703064 |
| keywords[3].display_name | In vitro |
| keywords[4].id | https://openalex.org/keywords/dna |
| keywords[4].score | 0.5048094987869263 |
| keywords[4].display_name | DNA |
| keywords[5].id | https://openalex.org/keywords/chemistry |
| keywords[5].score | 0.4978213310241699 |
| keywords[5].display_name | Chemistry |
| keywords[6].id | https://openalex.org/keywords/antibody |
| keywords[6].score | 0.49463793635368347 |
| keywords[6].display_name | Antibody |
| keywords[7].id | https://openalex.org/keywords/pharmacology |
| keywords[7].score | 0.41680359840393066 |
| keywords[7].display_name | Pharmacology |
| keywords[8].id | https://openalex.org/keywords/cancer-research |
| keywords[8].score | 0.3626246154308319 |
| keywords[8].display_name | Cancer research |
| keywords[9].id | https://openalex.org/keywords/molecular-biology |
| keywords[9].score | 0.33821266889572144 |
| keywords[9].display_name | Molecular biology |
| keywords[10].id | https://openalex.org/keywords/biology |
| keywords[10].score | 0.2788214087486267 |
| keywords[10].display_name | Biology |
| keywords[11].id | https://openalex.org/keywords/biochemistry |
| keywords[11].score | 0.2344309389591217 |
| keywords[11].display_name | Biochemistry |
| keywords[12].id | https://openalex.org/keywords/immunology |
| keywords[12].score | 0.22591325640678406 |
| keywords[12].display_name | Immunology |
| keywords[13].id | https://openalex.org/keywords/mathematics |
| keywords[13].score | 0.09598684310913086 |
| keywords[13].display_name | Mathematics |
| language | en |
| locations[0].id | doi:10.1158/1535-7163.22508386.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1535-7163.22508386.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22508386 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Table_S2_from_A_New_Class_of_Antibody_Drug_Conjugates_with_Potent_DNA_Alkylating_Activity/22508386 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5101664765 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3762-3319 |
| authorships[0].author.display_name | Michael L. Miller |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Michael L. Miller |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5038327301 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Nathan Fishkin |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nathan E. Fishkin |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5100318325 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9522-4474 |
| authorships[2].author.display_name | Wěi Li |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Wei Li |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5059443646 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Kathleen R. Whiteman |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kathleen R. Whiteman |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5062197147 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Yelena Kovtun |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yelena Kovtun |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5068001901 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Emily E. Reid |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Emily E. Reid |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5034382136 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Katie E. Archer |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Katie E. Archer |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5044927421 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-7905-1905 |
| authorships[7].author.display_name | Erin K. Maloney |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Erin K. Maloney |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5026129612 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Charlene A. Audette |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Charlene A. Audette |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5035319804 |
| authorships[9].author.orcid | https://orcid.org/0009-0005-0359-7900 |
| authorships[9].author.display_name | Michele Mayo |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Michele F. Mayo |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5076108317 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Alan Wilhelm |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Alan Wilhelm |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5071970655 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Holly A. Modafferi |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Holly A. Modafferi |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5104111164 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Rajeeva Singh |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Rajeeva Singh |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5050064612 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Jan Pinkas |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Jan Pinkas |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5074663002 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Victor S. Goldmacher |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Victor Goldmacher |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5036231578 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-7159-2195 |
| authorships[15].author.display_name | John M. Lambert |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | John M. Lambert |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5112381046 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-2373-5435 |
| authorships[16].author.display_name | Ravi Chari |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Ravi V.J. Chari |
| authorships[16].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1535-7163.22508386.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Table S2 from A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10755 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9902999997138977 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | HER2/EGFR in Cancer Research |
| related_works | https://openalex.org/W4365135407, https://openalex.org/W2004647072, https://openalex.org/W2143004018, https://openalex.org/W3186246047, https://openalex.org/W4220995267, https://openalex.org/W2030622236, https://openalex.org/W4281745809, https://openalex.org/W2031570580, https://openalex.org/W2404477942, https://openalex.org/W2362739353 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1535-7163.22508386.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1535-7163.22508386.v1 |
| primary_location.id | doi:10.1158/1535-7163.22508386.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1535-7163.22508386.v1 |
| publication_date | 2023-04-03 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.a | 7 |
| abstract_inverted_index.in | 1 |
| abstract_inverted_index.of | 4 |
| abstract_inverted_index.(2) | 14 |
| abstract_inverted_index.and | 12, 17 |
| abstract_inverted_index.(1), | 9 |
| abstract_inverted_index.(3), | 11 |
| abstract_inverted_index.IGNs | 5 |
| abstract_inverted_index.cell | 20 |
| abstract_inverted_index.with | 6 |
| abstract_inverted_index.solid | 18 |
| abstract_inverted_index.tumor | 19 |
| abstract_inverted_index.vitro | 2 |
| abstract_inverted_index.diamine | 13 |
| abstract_inverted_index.diimine | 8 |
| abstract_inverted_index.potency | 3 |
| abstract_inverted_index.towards | 15 |
| abstract_inverted_index.monoimine | 10 |
| abstract_inverted_index.hematologic | 16 |
| abstract_inverted_index.lines</p> | 21 |
| abstract_inverted_index.<p>Comparative | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 17 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6299999952316284 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.31317981 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |